Global Pancreatitis Therapeutics Report 2016 - Pipeline Review of 11 Companies & 23 Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Pancreatitis - Pipeline Review, H2 2016" report to their offering.

'Pancreatitis - Pipeline Review, H2 2016'; Pancreatitis pipeline therapeutics constitutes close to 23 molecules. Out of which approximately 19 molecules are developed by Companies and remaining by the Universities

Institutes.

The report 'Pancreatitis - Pipeline Review, H2 2016' outlays comprehensive information on the therapeutics under development for Pancreatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

Pancreatitis is an inflammation of pancreas. Symptoms include upper abdominal pain, nausea, vomiting, and tenderness when touching the abdomen, weight loss and upper abdominal pain. Predisposing factors include alcoholism, smoking, family history of pancreatitis, infection, injury to the abdomen and pancreatic cancer. Treatment includes antibiotics and medication to relieve pain.

It also reviews of key players involved in therapeutic development for Pancreatitis and features dormant and discontinued projects. Currently, The molecules developed by Companies in Phase II, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 1, 13, 3 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 4 molecules, respectively.

Key Topics Covered:

  1. Introduction
  2. Pancreatitis Overview
  3. Therapeutics Development
  4. Pipeline Products for Pancreatitis - Overview
  5. Pipeline Products for Pancreatitis - Comparative Analysis
  6. Pancreatitis - Therapeutics under Development by Companies
  7. Pancreatitis - Therapeutics under Investigation by Universities/Institutes
  8. Pancreatitis Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Pancreatitis - Products under Development by Companies
  13. Pancreatitis - Products under Investigation by Universities/Institutes
  14. Pancreatitis - Companies Involved in Therapeutics Development
  • Angion Biomedica Corp.
  • Atox Bio Ltd.
  • Bharat Serums And Vaccines Limited
  • CalciMedica, Inc.
  • Dynavax Technologies Corporation
  • Generon (Shanghai) Corporation Ltd.
  • GlaxoSmithKline Plc
  • LipimetiX Development Inc
  • Novartis AG
  • Pharming Group N.V.
  • Sun BioPharma, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/5kpznj/pancreatitis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Gastrointestinal Drugs , Endocrine and Metabolic Disorder Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Gastrointestinal Drugs , Endocrine and Metabolic Disorder Drugs